VGLL4 and gastric neoplasm: The administration of this peptide significantly repressed YAP activation and gastric tumor growth, indicating that the targeting of YAP/TAZ-TEAD complex by the VGLL4-mimicking peptide is a promising therapeutic strategy for various tumors.